TítuloReal life experience with direct acting antivirals agents against hepatitis C infection in elderly patients

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. Hepatitis C

Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Hepatitis C virus infection in chronic kidney disease.

Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C..

We compared patient characteristics, fibrosis work-up and antiviral treatment outcomes in TM (n = 157) and non-TM (n = 1,130) patients (The Ottawa Hospital Viral Hepatitis

To determine the SVR rate in patients ≥ 60 years with genotype 1 chronic hepatitis C treated with Peg-IFN and ribavirin, and to identify risk factors related to treatment response

Using peginter- feron alpha-2b plus ribavirin for 24 weeks to treat patients with HCV genotype 1 + 2 achieved a 74.1% sus- tained virological response rate; the treatment efficacy

The aim of this study was to determine the effica- cy and safety of pegylated interferon alfa-2b and ri- bavirin combination therapy in chronically infected patients with HCV genotype

Assessment of Haematological and Immunological Effect after New Direct Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients Sahar Ez Eldeen Hussein1, Howaida Abdel